期刊文献+

重组人生长激素对大面积烧伤的治疗作用 被引量:7

Effectiveness of Recombinant Human Growth Hormone Treatment for Sever e Burn Injury
下载PDF
导出
摘要 为了探讨重组人生长激素治疗大面积 烧伤的有效性和安全性,将伤后24小 时内入院的大面积烧伤患者随机分为治疗组和对照组,每组各10例。治疗组从第3天开始每 日给予重组人生长激素0.5 IU/kg皮下注射,持续14天,对照组则每 日给予安慰剂。此外,两组患者Ⅲ度创面均早期切痂植皮,Ⅱ度创面保守治疗,其余治疗基 本相同,直至创面痊愈。治疗期间定期检测患者的血红蛋白、血清白蛋白、代谢率、深Ⅱ度 创面及供皮区的愈合时间、体重变化、住院时间和感染发生情况。结果:治疗组血红蛋白、 血清白蛋白和代谢率较对照组增高,深Ⅱ度创面和供皮区愈合时间及住院时间较对照组缩短 ,体重下降减少,感染发生减少。治疗组有2例曾出现持续性高血糖,经短暂使用胰岛素后 恢复正常,其余未见明显副作用。上述结果表明,重组人生长激素对大面积烧伤患者有明显 的治疗作用,并且是安全的。 In order to investigate the effectiveness and safety of recomb inant hu man growth hormone(rhGH) treatment for severe burn injury, we designed a randomi zed prospective study.The patients in rhGH group were given rhGH in a dose of 0 .5 IU/(kg穌) subcutaneously between days 3-17 post-burn. Indices about protei n me tabolism, wound healing, hepatic and renal function and blood were measured regu larly. Patients were monitored until their wound healed sufficiently so that the y could be discharged for rehabilitation. The results showed: all patients survi ved; the rhGH group had less weight loss,increased level of serum albumin and s horter healing time of deep partial-thickness burn and donor site. The hospital stay time decreased from the control value of 45±17 days to 37±12 days for rhG H treated patients, i.e. a significant improvement. Resistant hyperglycemia was present in 2 patients in the rhGH group and disappeared after transient insulin administration. This study demonstrates that rhGH treatment for severe burn inju ry has obvious beneficial effects with slight side-effects.
出处 《华西医科大学学报》 CSCD 2000年第3期399-401,共3页 Journal of West China University of Medical Sciences
关键词 重组人生长激素 大面积烧伤 临床试验 Recombinant human growth hormone Burn Clinical trail
  • 相关文献

参考文献10

  • 11.Ramirez RJ, Wolf SE, Barrow RE, et al. Growth hormone treatment in pediatric burns: a safe therapeutic approach. Ann Surg, 1998; 228(4):439
  • 22.Jeevanandam M, Ramos L, Shamos R, et al. Decreased growth hormone levels in the catabolic phase of severe injury. Surgery, 1992; 111(5):495
  • 33.Shaw J, Wildbore M, Wolfe R. Whole body protein kinetics in severely septic patients. Ann Surg, 1987; 205(3):288
  • 44.Knox J, Demling R, Wilmore D, et al. Increased survival after major thermal injury: the effect of growth hormone therapy in adults. J Trauma, 1995; 39(3):526
  • 55.Herndon DN, Hawkins HK, Nguyen TT, et al. Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns.Ann Surg, 1995; 221(6):649
  • 66.Barret JP, Dziewulski P, Jeschke MG, et al. Effects of recombinant human growth hormone on the development of burn scarring. Plast Reconstr Surg, 1999; 104(3):726
  • 77.Klein GL, Wolf SE, Langman CB, et al. Effect of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe burn injury. J Clin Endocrinol Metab, 1998; 83(1):21
  • 88.Cioffi WG, Gore DC, Rue LW, et al. Insulin-like growth factor-I lowers protein oxidation in patients with thermal injury. Ann Surg, 1994; 220(3):310
  • 99.Jarrar D, Wolf SE, Jeschke MG, et al. Growth hormone attenuates the acute-phase response to thermal injury. Arch Surg, 1997; 132(11):1171
  • 1010.Demling RH. Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury. Burn, 1999; 25(2):215

同被引文献69

引证文献7

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部